Although we show robust associations of neural fragility and neural excitability with protein aggregates in our multimodal imaging cohorts, we did not have Aβ-PET and tau-PET imaging in all our sub-cohorts, which were characterized for epileptiform manifestations as AD-EPI+ and AD-EPI − . This evidence concerns the gene MAPT and Alzheimer disease.